Granules India share news, announcements and annual reports
NSE: GRANULESBSE: 532482Pharmaceuticals & BiotechnologySmall Cap
Granules India Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2002 on BSE, Jun 2005 on NSE
Last close ₹820.70down ₹19.05 (2.27%)BSE ₹819.55
Share price at the NSE close on 2 Nov 2026. Previous close ₹839.75.
2 Nov: open ₹838.50, high ₹849.15, low ₹808.30
52-week range of traded prices to 2 Nov 2026
₹529.85Low, 25 Nov 2025₹923.65High, 15 Sep 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22,387 Cr403rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.37
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.21%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.09
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,81,68346.1% delivered
Granules India share news and announcements
1,067 announcements, routine notices left out, newest first. Page 14 of 22.
Oct 2016
25 Oct · Board meeting
25 Oct · Results
Sep 2016
8 Sep · Analysts
Aug 2016
12 Aug · Regulation 44(3) of SEBI (LODR), Reg., 2015
11 Aug · Corporate action
3 Aug · Analysts
Jul 2016
20 Jul · Legal
Exchange has sought clarification from Granules India Limited with respect to an announcement submitted to the Exchange dated July 14, 2016, regarding a press release dated July 14, 2016, titled "Granules Pharmaceuticals, Inc., a wholly owend subsidiary of Granules India Limited, entered in to an agreement with USpharma for acquiring its stake".On basis of above Company are required to clarify following -1. Name of the target entity, details in brief such as size, turnover etc;2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arm's length";3. Brief details of any governmental or regulatory approvals required for the acquisition;4. Indicative time period for completion of the acquisition;5. Cost of acquisition or the price at which the shares are acquired;6. Nature of consideration - whether cash consideration or share swap and details of the same;7. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief).The response of the Company is awaited.12 Jul · Meeting
1 Jul · Analysts
Jun 2016
May 2016
25 May · Analysts
Apr 2016
29 Apr · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from August 5, 2016 to August 11, 2016 (both days inclusive)for the purpose of Annual General Meeting scheduled to be held on August 11, 2016 and payment of final dividend for the FY 2015-16.28 Apr · Board meeting
Mar 2016
28 Mar · Analysts
17 Mar · Analysts
Feb 2016
Jan 2016
29 Jan · Analysts